NaresJ31.0

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Non-allergic Rhinitis with Eosinophilia Syndrome; Rhinitis non-allergic with eosinophilia

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Acronym for "non-allergic rhinitis with eosinophilia syndrome". The clinical picture is defined by a non-allergic inflammation of the nasal mucosa associated with eosinophilia. This clinical constellation usually occurs together with nasal polyps.

EtiopathogenesisThis section has been translated automatically.

A precursor symptom of an acetylsalicylic acid-sensitive rhinitis is discussed. Recently, mainly autoimmune phenomena have been discussed.

ManifestationThis section has been translated automatically.

30-40 years

Clinical featuresThis section has been translated automatically.

Clinically, NARES is characterized by perennial rhinitis with nasal obstruction of breathing, recurrent sneezing attacks and possibly low-viscosity rhinorrhea. Associated are adenoids, recurrent infections, headache or head pressure related, intrinsic bronchial asthma.

LaboratoryThis section has been translated automatically.

Eosinophilia and elevated levels of tryptase, ECP, IL-1beta, IL-4, IL-6, IL-17, IFN-gamma, TNF-α and MCP-1 are detected in the nasal secretion of NARES.

DiagnosisThis section has been translated automatically.

Detection of eosinophilic granulocytes in the exfoliative cytology of the mucosa. Exclusion of an allergic genesis. Detection of possibly associated diseases like nasal polyps, intrinsic bronchial asthma.

TherapyThis section has been translated automatically.

The therapy of NARES has so far mainly consisted in the long-term administration of topical corticosteroids, possibly in combination with surgical measures.

Successes have been achieved with systemically applied interferons (e.g. Roferon).

LiteratureThis section has been translated automatically.

  1. Becker S et al (2016) Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa. Eur Arch Otorhinolaryngol 273:1469-1475
  2. Cassano M et al (2011) Nares patients have more respiratory infections than allergic subjects. Int J Immunopathol Pharmacol 24:813-815.
  3. Cavone L et al (2015) Increase in the Level of Proinflammatory Cytokine HMGB1 in Nasal Fluids of Patients With Rhinitis and its Sequestration by Glycyrrhizin Induces Eosinophil Cell Death. Clin Exp Otorhinolaryngol 8:123-128.
  4. Gröger M et al (2012) Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol 159:171-178.
  5. Moneret-Vautrin DA et al (1990) Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 64:513-518
  6. Perić A et al (2016) Nonselective chemokine levels in nasal secretions of patients with perennial nonallergic and allergic rhinitis. Int Forum Allergy Rhinol 6:392-397.

Authors

Last updated on: 29.10.2020